Live Breaking News & Updates on Etabolic|Page 1

Stay updated with breaking news from Etabolic. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

iGlarLixi Safe and Effective in Inadequately Controlled T2D

A once-daily injectable therapy of a fixed-ratio combination of insulin glargine and lixisenatide improved glycemic control, with low rates of hypoglycemia, in people with T2D in a real-world setting. ....

United States , Rayaza Malik , Qatar Foundation , Research Division , American Diabetes , European Association , Weill Cornell Medicine Qatar , Education City , Diabetes Mellitus Type 2 , Iabetes Mellitus Type Ii , Type 2 Diabetes , Ype 2 Dm , Board Certification , Oard Recertification , Office Visits , Patient Visits ,